Sarah Douglas-Martinez is a visionary healthcare executive with more than 20 years of experience leading enterprise growth and innovation across diagnostics, healthcare delivery, and value-based care models. As Executive Sales Leader for National Accounts at Labcorp, she oversees a $700 million portfolio and drives strategic partnerships with leading provider systems and value-based organizations. Known for her collaborative leadership and consultative approach, Sarah has a proven track record of aligning diagnostics and digital health solutions with transformative care models. Her expertise spans national sales strategy, CMS-aligned care coordination, and outcome-driven partnerships that deliver both clinical and financial results.

In today’s rapidly evolving healthcare landscape, strategic innovation requires more than cutting-edge technology—it demands deep clinical insight and a relentless focus on patient-centered care. From pioneering early web-based EMRs like Medicfusion to leading AI-driven platforms at QurHealth, my journey has underscored a central truth: true progress happens when empathy meets execution. Whether enhancing workflows for small practices or deploying conversational AI to proactively support Medicare patients, the goal remains the same—to deliver smarter, scalable, and more compassionate care that meets people where they are.

Over the years, I’ve worked at the intersection of healthcare, finance, and real estate—serving patients, growing businesses, and revitalizing communities. My mission is rooted in faith, equity, and truth, and I’m proud of the path that has shaped my leadership and impact. Here is my biography.

Amid soaring healthcare costs and overwhelming administrative burdens, artificial intelligence is emerging as a critical remedy for the industry’s inefficiencies. With clinicians losing valuable hours to fragmented systems and data silos, Novus Nexum Labs advocates for a transformative shift toward on-premises AI infrastructure. Unlike cloud-based solutions, this approach offers unparalleled data sovereignty, performance optimization, and regulatory compliance—enabling healthcare providers to streamline operations, reclaim time for patient care, and recapture lost revenue. As institutions like the University of Ottawa embrace unified, memory-safe AI platforms, the path forward is clear: a simplified, intelligent infrastructure that delivers measurable ROI and empowers medical professionals to lead, not lag, in the evolution of care.

Arup Pramanik is a globally recognized healthcare executive who has spent 25 years transforming how innovation reaches patients. With deep expertise in market access, pricing strategy, and digital health, Arup has led major global initiatives across top pharmaceutical companies including Boehringer Ingelheim, Novartis, and Takeda. Known for uniting science with strategy, he has reshaped commercialization pathways through AI, real-world evidence, and value-based models—delivering outcomes that benefit both enterprise growth and health equity. Now preparing for board roles, Arup brings unmatched global insight, cross-sector leadership, and a bold vision for patient-centered innovation.

In today’s evolving healthcare ecosystem, fostering meaningful patient engagement is crucial for improving outcomes and satisfaction. Leveraging AI-powered tools like QurHealth’s conversational assistant, Sheela, offers a breakthrough in scalable, personalized care. By adapting to each patient’s needs, Sheela supports recovery, boosts adherence, and delivers tailored health education—making interactions feel human and relevant. More than just automation, this approach frees clinicians to focus on high-acuity care while empowering patients to take an active role in their health journey. The result is a more efficient, responsive, and human-centered healthcare experience.

Miguel Nogueras is a globally recognized executive leader in microbiological quality and sterility assurance, known for driving innovation, regulatory excellence, and inclusive leadership across the pharmaceutical, medical device, and consumer health industries. With more than two decades of experience, he has built and led high-performing global teams, established end-to-end quality systems, and introduced advanced contamination control strategies that ensure patient safety and accelerate product delivery. Fluent in multiple languages and deeply committed to mentorship and diversity, Miguel blends scientific expertise with business acumen to deliver sustainable, compliant, and forward-thinking solutions in dynamic global markets.

With nearly 40 years in behavioral healthcare, I’ve been fortunate to serve in roles ranging from mental health technician to CEO and strategic advisor. My journey has included founding and growing a national treatment organization, guiding companies through successful acquisitions, and helping healthcare leaders enhance operational performance and enterprise value. Today, through my consulting work and advisory roles, I remain passionate about supporting innovation and sustainable growth in behavioral health.

I’m honored to share a snapshot of my professional journey, which spans over 30 years in nursing, education, and clinical leadership. From working with patients across the lifespan to mentoring the next generation of nurse practitioners and leading graduate programs, my mission has always been grounded in service, growth, and excellence. Here is my biography.

I’m passionate about building digital health solutions that empower people to take control of their healthcare journeys. Over the past decade, I’ve led MEMOTEXT and co-founded A4i Inc., a joint venture with CAMH, to bring data-driven, personalized engagement tools to life—especially in mental health. With a background in information systems and a career spanning healthcare, real estate, and consulting, I’m driven by a simple philosophy: create smarter systems that integrate people, process, and technology to make a lasting impact.

I'm a global medical affairs leader with over two decades of experience spanning clinical research, regulatory strategy, and pharmaceutical innovation across Latin America and the United States. Throughout my career, I've had the privilege of guiding high-performing teams, launching impactful therapies, and aligning regional execution with global vision—most recently as Head of Medical Affairs for Emerging Therapy Areas at Novo Nordisk. Passionate about advancing patient outcomes and fostering collaborative leadership, I bring a strategic, people-centered approach to everything I do in the healthcare space.

I’m excited to share a glimpse into my professional journey—a path shaped by innovation, transformation, and a deep commitment to excellence in pharmaceutical quality and compliance. Over the past 23 years, I’ve had the privilege of leading high-impact initiatives at the intersection of operations, strategy, and people development. Here is my biography.

I’m a healthcare executive with over a decade of experience leading clinical operations, hospital strategy, and system-wide transformation in both domestic and international settings. My journey has taken me from launching a specialty hospital in Saudi Arabia to overseeing multimillion-dollar initiatives across California hospitals, where I’ve served as COO, CNO, and Patient Care Executive. With a foundation in nursing, a Doctorate in Healthcare Administration, and a passion for community impact, I’m committed to advancing patient-centered care, operational excellence, and leadership development across every level of the health system.

Dr. Steven R. Goldstein is an internationally renowned expert in gynecologic ultrasound and women’s midlife health. As a tenured Professor of Obstetrics and Gynecology at NYU Grossman School of Medicine, his career spans over four decades of pioneering research, clinical innovation, and global education. Dr. Goldstein has served as President of the American Institute of Ultrasound in Medicine, the North American Menopause Society, and the International Menopause Society, reflecting his influential leadership across multiple disciplines. A prolific author and sought-after speaker, he has transformed the standards of care for menopause, osteoporosis, and abnormal uterine bleeding, while mentoring generations of physicians and shaping the future of women's healthcare worldwide.

Christi Fedak is a seasoned healthcare professional with nearly two decades of experience blending clinical expertise with healthcare IT leadership. Currently serving as an Application Systems Analyst at UNC Health, she specializes in Epic Systems optimization, workflow improvements, and strategic project management. With certifications in nuclear medicine and a background in cardiovascular technology, Christi brings a rare dual perspective to her work—bridging patient care and technology with precision and empathy. Known for her resilience, collaborative spirit, and service-driven mindset, she is now seeking board opportunities where she can extend her impact and support mission-driven organizations in the medical, community, and wellness sectors.

Tammy Earnhardt is a nationally respected Behavioral Health Strategic Advisor with over three decades of leadership experience in transforming healthcare systems. Known for her integrity, operational acumen, and ability to navigate complex regulatory environments, Tammy has led multi-state expansions, integrated care innovations, and high-impact mergers and acquisitions. As the founder of Earnhardt Consulting and former Senior Vice President of Strategy at Health Connect America, she brings a rare blend of executive insight, strategic vision, and deep sector knowledge to every organization she partners with. Passionate about helping others grow, she now seeks board service opportunities where she can contribute her expertise to organizations committed to meaningful impact in behavioral health and child welfare.